Bellafill is 20%
PMMA spheres per 0.8mL syringe, giving you 0.16mL of
PMMA spheres per syringe. 20 syringes would give you 3.2mL of
PMMA spheres (20 * 0.8 * 0.2)
Linnea 30% is 30%
PMMA spheres per 1.0mL syringe, giving you 0.3mL of
PMMA spheres per syringe. 20 syringes would give you 6.0mL of
PMMA spheres
Linnea 10% is 10%
PMMA spheres per 1.0mL syringe, giving you 0.1mL of
PMMA spheres per syringe. 20 syringes would give you 2.0mL of
PMMA spheres.
A typical Avanti visit would be something like 13 syringes x 30%, 7 syringes x 10% (estimating). That would give you 4.6mL of
PMMA microspheres in a 20 syringe procedure.
I mention the
PMMA sphere volume because that's what will remain in your body when the carrier is gone.
Your first procedure was 15 syringes of 0.8mL for 12mL total injected, 2.4mL of which were
PMMA microspheres.
Not a perfect apples to apples and there may be other differences besides carrier that are way above my pay grade, but your 15mL session gave you about half the
PMMA microsphere volume you'd get from a typical Avanti session of 20mL.
I don't know enough to know if concentration and carrier are all that matters when looking at results. I'm sure pharma sales people and doctors have discussions that are above my head about the pros and cons of different products performing similar. tasks. But if the ONLY variable is "cost per mL of injected
PMMA microspheres" - and that isn't of course the only variable, but - there is a reason it's not uncommon for people to fly to MX for medical work and still save money. The cost is an advantage for the time being.